1,25-dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro

被引:0
|
作者
Cornet, A
Baudet, C
Neveu, I
Baron-Van Evercooren, A
Brachet, P
Naveilhan, P [1 ]
机构
[1] Karolinska Inst, MBB, Mol Neurobiol Lab, Dept Med Chem Biophys, S-17177 Stockholm, Sweden
[2] CHU Angers, INSERM U298, Angers, France
[3] Hop La Pitie Salpetriere, INSERM CJF 96 08, Paris, France
关键词
vitamin D; Schwann cells; gene regulation;
D O I
10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The vitamin D receptor (VDR) is a nuclear receptor that mediates the effect of the active metabolite of vitamin D3, the 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), To investigate the potential role of this hormone in the peripheral nervous system, we have studied the VDR expression in Schwann cells. The VDR mRNA was detected by Northern blot analysis in rat primary cultures of Schwann cells, and its levels were strongly increased in the presence of 1,25(OH)2D3, Using the mouse Schwann cell line, MSC80, we showed that concentrations as low as 10(-10) M of hormone stimulated the expression of the VDR gene and strongly increased the amounts of activated VDR, capable of binding to the specific vitamin D responsive element (VDRE), We also found that 1,25-(OH)2D3 stimulated the expression of the nerve growth factor gene in MSC80, These data suggest a role for the hormone in the peripheral nervous system, possibly as a mediator actived in trauma. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 50 条
  • [2] Regulation of gene expression by 1,25-dihydroxyvitamin D3
    DeLuca, HF
    CANCER AND NUTRITION, 1998, : 55 - 69
  • [3] Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate
    Kivineva, M
    Bläuer, M
    Syvälä, H
    Tammela, T
    Tuohimaa, P
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 66 (03): : 121 - 127
  • [4] The effects of 1,25-dihydroxyvitamin D3 on angiogenesis in vitro
    Mantell, DJ
    Mawer, EB
    Bundred, NJ
    Canfield, AE
    JOURNAL OF VASCULAR RESEARCH, 1998, 35 (05) : 390 - 390
  • [5] EFFECT OF 1,25-DIHYDROXYVITAMIN D3 ON THE IMMUNOCOMPETENT CELLS
    HOSHINO, T
    IHO, S
    KURA, F
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1986, 8 (03): : 167 - 173
  • [6] Differentiation of myeloid cells and 1,25-dihydroxyvitamin D3
    Takahashi, T
    Nakamura, K
    Iho, S
    LEUKEMIA & LYMPHOMA, 1997, 27 (1-2) : 25 - &
  • [7] Analysis of 1,25-dihydroxyvitamin D3 receptors (VDR) in basal cell carcinomas
    Reichrath, J
    Kamradt, J
    Zhu, XH
    Kong, XF
    Tilgen, W
    Holick, MF
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02): : 583 - 589
  • [8] 1,25-DIHYDROXYVITAMIN D3 AND PSEUDOHYPOPARATHYROIDISM
    SINHA, TK
    BELL, NH
    NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (11): : 612 - 612
  • [9] 1,25-DIHYDROXYVITAMIN D3 AND THE TESTIS
    WALTERS, MR
    OSMUNDSEN, BC
    CARTER, RM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 513 : 482 - 484
  • [10] In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3
    Pourgholami, MH
    Akhter, J
    Lu, Y
    Morris, DL
    CANCER LETTERS, 2000, 151 (01) : 97 - 102